Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
CStone Pharmaceuticals
Scientific Title
A Phase I, Multi-center, Open-label, Dose Escalation Study of CS3005 in Subjects With Advanced Solid Tumors